APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,513,016 | +319.5% | 278,964 | +672.7% | 0.01% | +250.0% |
| Q2 2023 | $3,221,199 | +13.0% | 36,104 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $2,851,020 | +120.8% | 36,873 | +42.7% | 0.00% | +100.0% |
| Q4 2022 | $1,291,383 | -26.4% | 25,838 | -15.0% | 0.00% | 0.0% |
| Q3 2022 | $1,754,000 | +885.4% | 30,408 | +675.1% | 0.00% | – |
| Q2 2022 | $178,000 | -19.5% | 3,923 | 0.0% | 0.00% | – |
| Q1 2022 | $221,000 | +38.1% | 3,923 | 0.0% | 0.00% | – |
| Q4 2021 | $160,000 | +24.0% | 3,923 | 0.0% | 0.00% | – |
| Q3 2021 | $129,000 | -48.0% | 3,923 | 0.0% | 0.00% | – |
| Q2 2021 | $248,000 | – | 3,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |